2000;130(5S Suppl):1412S-S1420
The most common adverse effects associated with the use of GLP-1 RAs are gastrointestinal symptoms
Overall prevalence peaks at weeks 8 to 12
How Primary Care Providers Monitor GLP-1 Treatment Effective primary care GLP-1 management includes structured follow-up at 2-4 weeks after initiation, then every 4-12 weeks to assess tolerability, weight loss trajectory, and medication adherence
Interestingly, various sphincter failures [10,64,110,111,113,180] were recovered, and glaucoma-mydriasis [110,113], atropine-mydriasis, L-arginine-induced prolonged miosis, and L-NAME-induced prolonged miosis [111] were counteracted
Topical application takes slightly more effort but is still straightforward